iShares Global Healthcare ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.
IXJ price
Table
| Date | IXJ close |
|---|---|
| Aug 17, 2026 | $102.28 |
| Aug 18, 2026 | $103.91 |
| Aug 19, 2026 | $107.36 |
| Aug 20, 2026 | $105.67 |
| Aug 21, 2026 | $106.85 |
| Aug 24, 2026 | $106.80 |
| Aug 25, 2026 | $107.48 |
| Aug 26, 2026 | $106.31 |
| Aug 27, 2026 | $105.17 |
| Aug 28, 2026 | $104.77 |
| Aug 31, 2026 | $104.24 |
| Sep 1, 2026 | $104.77 |
| Sep 2, 2026 | $105.70 |
| Sep 3, 2026 | $106.05 |
| Sep 4, 2026 | $104.90 |
| Sep 8, 2026 | $101.91 |
| Sep 9, 2026 | $101.40 |
| Sep 10, 2026 | $100.89 |
| Sep 11, 2026 | $100.76 |
| Sep 14, 2026 | $102.27 |
| Sep 15, 2026 | $102.16 |
| Sep 16, 2026 | $102.05 |
| Sep 17, 2026 | $102.86 |
| Sep 18, 2026 | $102.49 |
| Sep 21, 2026 | $103.18 |
| Sep 22, 2026 | $103.66 |
| Sep 23, 2026 | $102.77 |
| Sep 24, 2026 | $103.36 |
| Sep 25, 2026 | $103.88 |
| Sep 28, 2026 | $104.11 |
| Sep 29, 2026 | $103.65 |
| Sep 30, 2026 | $102.12 |
| Oct 1, 2026 | $100.93 |
| Oct 2, 2026 | $100.86 |
| Oct 5, 2026 | $101.47 |
| Oct 6, 2026 | $101.37 |
| Oct 7, 2026 | $102.33 |
| Oct 8, 2026 | $101.78 |
| Oct 9, 2026 | $103.17 |
| Oct 12, 2026 | $103.73 |
| Oct 13, 2026 | $102.71 |
| Oct 14, 2026 | $105.06 |
| Oct 15, 2026 | $107.21 |
| Oct 16, 2026 | $106.93 |
| Oct 19, 2026 | $106.43 |
| Oct 20, 2026 | $109.10 |
| Oct 21, 2026 | $108.79 |
| Oct 22, 2026 | $110.35 |
| Oct 23, 2026 | $109.40 |
| Oct 26, 2026 | $109.35 |
| Oct 27, 2026 | $109.25 |
| Oct 28, 2026 | $109.36 |
| Oct 29, 2026 | $111.74 |
| Oct 30, 2026 | $112.66 |
| Nov 2, 2026 | $112.57 |
| Nov 3, 2026 | $111.96 |
| Nov 4, 2026 | $115.53 |
| Nov 5, 2026 | $112.89 |
| Nov 6, 2026 | $112.96 |
| Nov 9, 2026 | $114.96 |
| Nov 10, 2026 | $114.97 |
| Nov 11, 2026 | $114.86 |
| Nov 12, 2026 | $114.26 |
| Nov 13, 2026 | $114.74 |
| Nov 16, 2026 | $114.23 |
Weekly net flows, 3M
Net inflow over the range: +$11M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Aug 10 | $0 |
| Aug 17 | $0 |
| Aug 24 | $0 |
| Aug 31 | $52.1M |
| Sep 7 | −$50.9M |
| Sep 14 | $107.8M |
| Sep 21 | −$26M |
| Sep 28 | $36.5M |
| Oct 5 | −$21.3K |
| Oct 12 | $4.8M |
| Oct 19 | −$108.4M |
| Oct 26 | −$1.3K |
| Nov 2 | −$16.8M |
| Nov 9 | $11.4M |
Money is leaving — −$114M in net outflows over the past month, about 2.4% of the fund's asset base, while the price has returned +17.3% so far this year. At 0.38% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 11.55% | $1431.67 | -0.8% | ||
| 2 | JNJJOHNSON & JOHNSON | 6.91% | $282.55 | -1.1% | ||
| 3 | ABBVABBVIE | 5.26% | $294.55 | -0.2% | ||
| 4 | UNHUNITEDHEALTH GROUP | 4.04% | $412.02 | +1.1% | ||
| 5 | MRKMERCK & CO | 4.03% | $144.46 | -2.2% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 2.88% | $691.33 | -1.3% | ||
| 7 | AMGNAMGEN | 2.81% | $462.32 | -0.7% | ||
| 8 | GILDGILEAD SCIENCES | 2.32% | $167.58 | -0.3% | ||
| 9 | SN.SHARKNINJA | 0.15% | $223.29 | -1.4% | ||
| 10 | ABTABBOTT LABORATORIES | 2.06% | $107.45 | -1.0% | ||
| 11 | PFEPFIZER | 1.83% | $28.86 | -0.1% | ||
| 12 | ISRGINTUITIVE SURGICAL | 1.73% | $437.75 | -1.3% | ||
| 13 | DHRDANAHER | 1.61% | $229.91 | -1.3% | ||
| 14 | VRTXVERTEX PHARMACEUTICALS | 1.53% | $537.79 | -0.2% | ||
| 15 | MCKMCKESSON | 1.40% | $1105.04 | +0.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 109Sector weights
- Health Care99.64%
- Pharma, Biotech & Life Sciences71.16%
- Health Care Equipment & Services28.47%
- Cash and/or Derivatives0.37%
Show as table
| Item | Value (%) |
|---|---|
| Health Care | 99.64% |
| Pharma, Biotech & Life Sciences | 71.16% |
| Health Care Equipment & Services | 28.47% |
| Cash and/or Derivatives | 0.37% |
Country weights
- United States73.39%
- Switzerland9.49%
- United Kingdom4.88%
- Japan3.43%
- France2%
- Denmark1.89%
- Germany1.69%
- Other1.11%
Show as table
| Item | Value (%) |
|---|---|
| United States | 73.39% |
| Switzerland | 9.49% |
| United Kingdom | 4.88% |
| Japan | 3.43% |
| France | 2% |
| Denmark | 1.89% |
| Germany | 1.69% |
| Other | 1.11% |
| 1 week | -0.6% |
| 1 month | +6.8% |
| 3 months | +11.5% |
| 6 months | +24.2% |
| YTD | +17.3% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$81K |
| 1 month | −$114M |
| 3 months | +$11M |
| YTD | −$491M |
| 1 year | −$390M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Nov | $85.7M |
| Dec | $53.3M |
| Jan | $55.7M |
| Feb | −$556.7M |
| Mar | −$243.2M |
| Apr | $18.7M |
| May | $0 |
| Jul | $198.1M |
| Aug | $25.5M |
| Sep | $119.5M |
| Oct | −$103.6M |
| Nov | −$5.3M |
The top holding is 11.5% of the book; the top ten carry 48%. Spread across 148+ names, it behaves like roughly 32 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $45M |
| UNH UNITEDHEALTH GROUP | $28M | $30M |
| MRNA MODERNA | $30M | $26M |
| BSX BOSTON SCIENTIFIC | $12M | $1M |
| JNJ JOHNSON & JOHNSON | $6M | $7M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IXJ on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -35bp on fee · 9× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -35bp on fee · 4× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -33bp on fee · 26× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -34bp on fee · 7× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -34bp on fee · 5× the assets · +$422M in over the month | Head-to-head |

